Call Now: +1 858 800 3101 Email: info@innopep.com
Shopping Cart
0 Item(s) - $0.00
Your shopping cart is empty!
CEF26, Influenza Virus NP (265 - 274)
ILRGSVAHK
| Overview | |
|---|---|
| Description | HLA-A*03 restricted epitope from influenza virus nucleoprotein (265-274). |
| Sequence | ILRGSVAHK |
| Sequence (3 Letter) | H - Ile - Leu - Arg - Gly - Ser - Val - Ala - His - Lys - OH |
| Molecular Weight | 980.2 |
| Properties | |
| Purity | % Peak Area By HPLC ≥ 95% |
| Storage | -20 °C |
Ref: DiBrino, M. et al. J. Immunol. 151, 5930 (1993); Macken, C. et al. “The value of a database in surveillance and vaccine selection.” in Options for the Control of Influenza IV. A.D.M.E. Osterhaus, N. Cox & A.W. Hampson (Eds.) Amsterdam: Elsevier Science, 103 (2001).
About InnoPep
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.